The Wall Street Journal’s Venture Capital Pro quoted a recent biopharma report from William Blair’s equity capital markets team, noting the uptick in activity for PIPEs among biopharma companies in 2023.

Investment Banking
The Wall Street Journal’s Venture Capital Pro quoted a recent biopharma report from William Blair’s equity capital markets team, noting the uptick in activity for PIPEs among biopharma companies in 2023.
Stay up-to-date with the latest William Blair news and insights
William Blair acted as exclusive financial advisor to Brightflag, a portfolio company of One Peak Partners, Sands Capital, Frontline Ventures, Tribal Ventures, and Enterprise Ireland, in connection with its pending sale to Wolters Kluwer (EURONEXT: WKL) for €425 million.
William Blair, the premier global partnership with expertise in investment banking, investment management, and private wealth management, announced today the continued growth of the firm’s Private Capital Advisory team in Europe with the addition of industry veteran Delaney Brown.
Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.
For disclosure information, please visit www.williamblair.com/disclosures